Herbas VPB

Print
EN | LT
LT - Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui
EN - MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/30 (2006.01)
A61K 39/395 (2006.01)
A61P 35/00 (2006.01)
C12N 5/12 (2006.01)
A61K 51/10 (2006.01)
A61K 45/06 (2006.01)
C07K 16/18 (2006.01)
C07K 16/28 (2006.01)
A61K 39/00 (2006.01)
A61K 47/68 (2017.01)
A61P 35/04 (2006.01)
A61P 43/00 (2006.01)
European patent
(11) Number of the document 3421498
(13) Kind of document T
(96) European patent application number 18185237.7
Date of filing the European patent application 2006-11-24
(97) Date of publication of the European application 2019-01-02
(45) Date of publication and mention of the grant of the patent 2022-01-05
(46) Date of publication of the claims translation 2022-03-10
Priority applications
(30) Number Date Country code
05025657 2005-11-24 EP
Inventors
(72)
Sahin, Ugur , DE
Türeci, Özlem , DE
Usener, Dirk , DE
Fritz, Stefan , DE
Uherek, Christoph , DE
Brandenburg, Gunda , DE
Geppert, Harald-Gerhard , DE
Schröder, Anja Kristina , DE
Thiel, Philippe , DE
Grantee
(73) Astellas Pharma Inc. , 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411, JP
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH , Freiligrathstrasse 12, 55131 Mainz, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Monokloniniai antikūnai prieš klaudiną-18, skirti vėžio gydymui
  MONOCLONAL ANTIBODIES AGAINST CLAUDIN-18 FOR TREATMENT OF CANCER
Last renewal fee
Payment date Validity (years) Amount
2024-10-31 19 347.00 EUR
Next renewal fee
2025-11-24